Fundraising Fox

Glaukos

NYSE: GKOS

Aliso Viejo, US · Founded 1998 · 1,150 employees on LinkedIn · 1 known investors

Glaukos develops micro-scale medical devices and pharmaceuticals for treating glaucoma, corneal disorders, and retinal diseases, replacing traditional drop therapies with minimally invasive surgery platforms. Founded in 1998 and publicly traded on the NYSE, the company serves ophthalmology patients globally.

Investors · 1

Competitors · 4

by search overlap

Companies competing with Glaukos for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Glaukos do?
Glaukos develops micro-scale medical devices and pharmaceuticals for treating glaucoma, corneal disorders, and retinal diseases, replacing traditional drop therapies with minimally invasive surgery platforms. Founded in 1998 and publicly traded on the NYSE, the company serves ophthalmology patients globally.
Who are Glaukos's investors?
Glaukos's investors include Avedro, Inc..
Where is Glaukos headquartered?
Glaukos is headquartered in Aliso Viejo, US.